Ranibizumab port delivery system: a clinical perspective

por Eichenbaum, David A, Ahmed, Abrahim, Hiya, Farhan
Publicado 2022

OPTIMAL MANAGEMENT OF PIGMENT EPITHELIAL DETACHMENTS IN EYES WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

por Khanani, Arshad M., Eichenbaum, David, Schlottmann, Patricio G., Tuomi, Lisa, Sarraf, David
Publicado 2018

Macular thickness amplitude changes when switching from discontinuous to continuous therapy for diabetic macular oedema

por Schechet, Sidney A, Adams, Olufemi E, Eichenbaum, David A, Hariprasad, Seenu M
Publicado 2019

Home Monitoring of Age-Related Macular Degeneration: Utility of the ForeseeHome Device for Detection of Neovascularization

por Yu, Hannah J., Kiernan, Daniel F., Eichenbaum, David, Sheth, Veeral S., Wykoff, Charles C.
Publicado 2020

Current and upcoming anti-VEGF therapies and dosing strategies for the treatment of neovascular AMD: a comparative review

por Khanna, Saira, Komati, Rahul, Eichenbaum, David A, Hariprasad, Ishani, Ciulla, Thomas A, Hariprasad, Seenu M
Publicado 2019

Two-year interim safety results of the 0.2 µg/day fluocinolone acetonide intravitreal implant for the treatment of diabetic macular oedema: the observational PALADIN study

por Mansour, Sam E, Kiernan, Daniel F, Roth, Daniel B, Eichenbaum, David, Holekamp, Nancy M, Kaba, Samer, Werts, Erica
Publicado 2021

Angiopoietins as Potential Targets in Management of Retinal Disease

por Khanani, Arshad M, Russell, Matthew W, Aziz, Aamir A, Danzig, Carl J, Weng, Christina Y, Eichenbaum, David A, Singh, Rishi P
Publicado 2021

Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial

por Patel, Sunil S., Lally, David R., Hsu, Jason, Wykoff, Charles C., Eichenbaum, David, Heier, Jeffrey S., Jaffe, Glenn J., Westby, Keith, Desai, Dhaval, Zhu, Liansheng, Khanani, Arshad M.
Publicado 2023

Correction: Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial

por Patel, Sunil S., Lally, David R., Hsu, Jason, Wykoff, Charles C., Eichenbaum, David, Heier, Jeffrey S., Jaffe, Glenn J., Westby, Keith, Desai, Dhaval, Zhu, Liansheng, Khanani, Arshad M.
Publicado 2023

IMPACT OF RETINAL FLUID-FREE MONTHS ON OUTCOMES IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: A Treatment Agnostic Analysis of the HAWK and HARRIER Studies

por Eichenbaum, David, Brown, David M., Ip, Michael, Khanani, Arshad M., Figueroa, Marta S., McAllister, Ian L., Laude, Augustinus, B, Guruprasad, Tang, Shuhan, Gmeiner, Benjamin, Clemens, Andreas, Souied, Eric
Publicado 2023

Impact of Modifying Abicipar Manufacturing Process in Patients with Neovascular Age-Related Macular Degeneration: MAPLE Study Results

por Callanan, David, Khurana, Rahul N, Maturi, Raj K, Patel, Sunil, Wykoff, Charles C, Eichenbaum, David, Khanani, Arshad M, Hassan, Tarek, Badger, Hanh, Mehta, Shraddha, Le, Grace, Attar, Mayssa, Seal, Jennifer, Li, Xiao-Yan
Publicado 2023

Real-World Performance of a Self-Operated Home Monitoring System for Early Detection of Neovascular Age-Related Macular Degeneration

por Ho, Allen C., Heier, Jeffrey S., Holekamp, Nancy M., Garfinkel, Richard A., Ladd, Byron, Awh, Carl C., Singh, Rishi P., Sanborn, George E., Jacobs, Jennifer H., Elman, Michael J., Loewenstein, Anat, Eichenbaum, David A.
Publicado 2021

Quantifying burden of intravitreal injections: questionnaire assessment of life impact of treatment by intravitreal injections (QUALITII)

por Wang, Rui, McClard, Cynthia K, Laswell, Stephen, Mahmoudzadeh, Raziyeh, Salabati, Mirataollah, Ammar, Michael, Vannavong, Jordyn, Aziz, Aamir A, Ewald, Amy, Calvanese, Allison V, Lehman, Erik B, Fried, Sagit, Windham, Victoria, Strutt, Adriana, Saroj, Namrata, Khanani, Arshad Mohammad, Eichenbaum, David A, Regillo, Carl, Wykoff, Charles Clifton
Publicado 2022